Tumors are one of the leading causes of death worldwide, with Lung, Breast, Colorectal, Prostate, Skin and Stomach Cancer the most commonly identified. It is estimated that 84 million people have lost their lives because of cancer between 2005 and 2015. Globally, about 1 in 6 deaths occur due to Cancer.

SciTech Pharma is committed to developing and discovering new medications in this fight against cancer so patients can once again live and embrace life.

Researchers and scientists have identified many different types of Autoimmune Disease, including Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Systemic Vasculitis among others. With a prevalence rate higher than most of the western countries, more than 5% of the population in China suffers from some types of Autoimmune Disease. With the outbreak of the Covid-19 pandemic, the Corona Virus that triggers an autoimmune storm in humans, thus causing death, has made the study of the autoimmune response even more important than ever.

SciTech Pharma is dedicated to discovering and developing innovative medications that help patients fight against this disease by providing advanced treatment options.

Affecting millions of predominantly elderly individuals, Alzheimer's Disease is the most common neurodegenerative disease and most common cause of Dementia worldwide. Every year in China, there are an average of 300,000 new cases of Alzheimer's Disease diagnosed and no effective treatment or therapeutic medication to reverse the disease progression.

With a mission of delivering meaningful solutions to these types of issues, SciTech Pharma is continuously looking for new opportunities that will bring real change to patients.